Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and cisplatin in advanced breast cancer
NCT01143974Phase 4Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jun 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pemetrexed in breast cancer, sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Progression-Free Survival at 2 years. Started Jun 2010; status: completed.
02
Drugs
pemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01143974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01143974.